[1]
2020. Relationship between painful manifestations and the use of hydroxyurea in children and adolescents with sickle cell disease. Research, Society and Development. 9, 10 (Oct. 2020), e6949109046. DOI:https://doi.org/10.33448/rsd-v9i10.9046.